AU709012B2 - Stable N-terminally linked DTPA:protein compositions and methods - Google Patents

Stable N-terminally linked DTPA:protein compositions and methods Download PDF

Info

Publication number
AU709012B2
AU709012B2 AU43667/96A AU4366796A AU709012B2 AU 709012 B2 AU709012 B2 AU 709012B2 AU 43667/96 A AU43667/96 A AU 43667/96A AU 4366796 A AU4366796 A AU 4366796A AU 709012 B2 AU709012 B2 AU 709012B2
Authority
AU
Australia
Prior art keywords
csf
dtpa
protein
rhg
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU43667/96A
Other languages
English (en)
Other versions
AU4366796A (en
Inventor
David C Litzinger
Lloyd D Ralph
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU4366796A publication Critical patent/AU4366796A/en
Application granted granted Critical
Publication of AU709012B2 publication Critical patent/AU709012B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU43667/96A 1994-11-17 1995-11-17 Stable N-terminally linked DTPA:protein compositions and methods Ceased AU709012B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34248194A 1994-11-17 1994-11-17
US08/342481 1994-11-17
PCT/US1995/015072 WO1996015816A2 (fr) 1994-11-17 1995-11-17 Compositions stables de proteines/acide diethylenetriamine pentacetique a liaison n-terminale et procedes associes

Publications (2)

Publication Number Publication Date
AU4366796A AU4366796A (en) 1996-06-17
AU709012B2 true AU709012B2 (en) 1999-08-19

Family

ID=23342010

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43667/96A Ceased AU709012B2 (en) 1994-11-17 1995-11-17 Stable N-terminally linked DTPA:protein compositions and methods

Country Status (5)

Country Link
EP (1) EP0796113A2 (fr)
JP (1) JPH10509179A (fr)
AU (1) AU709012B2 (fr)
MX (1) MX9703549A (fr)
WO (1) WO1996015816A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO066096A0 (en) * 1996-06-26 1996-07-18 Peptide Delivery Systems Pty Ltd Oral delivery of peptides
US6017876A (en) * 1997-08-15 2000-01-25 Amgen Inc. Chemical modification of granulocyte-colony stimulating factor (G-CSF) bioactivity
CA2359573C (fr) 1999-01-19 2010-04-20 Biostream, Inc. Conjugues de facteurs stimulant les colonies cellulaires pour cibler et visualiser des infections et des inflammations
IT201900011013A1 (it) 2019-07-05 2021-01-05 Sapienza Univ Di Roma Composto e composizione radiofarmaceutici per l’imaging con tecnica di Tomografia a Emissione di Positroni (PET) di cellule positive al recettore dell’interleuchina-2, processo per la loro preparazione, relativo kit e loro usi.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991000111A1 (fr) * 1989-06-23 1991-01-10 Cancer Research Campaign Technology Limited Agents de ciblage

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991000111A1 (fr) * 1989-06-23 1991-01-10 Cancer Research Campaign Technology Limited Agents de ciblage

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J. NUCL.MED 24/12 (1983) PP 1158-1163, PAEK ET AL. *
J. RADIOANAL NUCL.CHEM,147/2 (1991)PP243-55,SHAFIQ ET AL *

Also Published As

Publication number Publication date
WO1996015816A2 (fr) 1996-05-30
WO1996015816A3 (fr) 1996-08-08
MX9703549A (es) 1998-02-28
EP0796113A2 (fr) 1997-09-24
JPH10509179A (ja) 1998-09-08
AU4366796A (en) 1996-06-17

Similar Documents

Publication Publication Date Title
US5225180A (en) Technetium-99m labeled somatostatin-derived peptides for imaging
EP3470418B1 (fr) Anticorps marqué par radioisotope spécifique d'un site utilisant un peptide liant une igg
AU649079B2 (en) Modified antibodies with controlled clearance time
FI81263C (fi) Foerfarande foer maerkning av en maolsoekande biologiskt aktiv molekyl och metalltionein.
DE69434086T2 (de) Herstellung und Verwendung von Immunkonjugaten die eine VL-Kette enthalten welche am Asn in Position 18 glykosyliert ist
Yoshikawa et al. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
US5277892A (en) In vivo lymphocyte tagging
Kobayashi et al. L-lysine effectively blocks renal uptake of 125I-or 99mTc-labeled anti-Tac disulfide-stabilized Fv fragment
Chianelli et al. The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases
WO1996014339A1 (fr) Anticorps
EP3783016A1 (fr) Anticorps modifié et anticorps marqué par un métal radioactif
US5728369A (en) Radioactive phosphorus labeling of proteins for targeted radiotherapy
US6008319A (en) Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
AU709012B2 (en) Stable N-terminally linked DTPA:protein compositions and methods
MXPA97003549A (en) Stable dietilentriaminopentaacetic acid, jointed by the end of n: compositions of protein and met
Verbeke et al. Technetium-99m mercaptoalbumin as a potential substitute for technetium-99m labelled red blood cells
CA2205064A1 (fr) Compositions stables de proteines/acide diethylenetriamine pentacetique a liaison n-terminale et procedes associes
Ralph et al. Site-specific conjugation of diethylenetriaminepentaacetic acid to recombinant human granulocyte-colony-stimulating factor: preservation of protein structure and function
US20030165427A1 (en) Tuftsin metallopeptide analogs and uses thereof
US5643549A (en) Leukostimulatory agent for in vivo leukocyte tagging
WO1993009816A1 (fr) Procede de diagnostic et de traitement du cancer
EP0700930A1 (fr) Peptides à affinité pour des tumeurs et composés radioactifs diagnostiques et thérapeutiques les contenant
Litzinger et al. A method for preparing chelate-cytokine conjugates with retention of protein structure, biological activity, and pharmacokinetic properties
EP0493526A1 (fr) Compositions de radionuclides therapeutiques stables et leurs procedes de preparation
US20220288245A1 (en) Radiopharmaceutical compound and composition for positron emission tomography (pet) imaging of interleukin-2 receptor positive cells, process for the preparation thereof, related kit and uses thereof

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired